Loss of COP1 expression determines poor prognosisin patients with gastric cancer

Sawada,Genta; Ueo,Hiroki; Matsumura,Tae; Uchi,Ryutaro; Ishibashi,Masahisa; Mima,Kosuke; Kurashige,Junji; Takahashi,Yusuke; Akiyoshi,Sayuri; Sudo,Tomoya; Sugimachi,Keishi; Doki,Yuichiro; Mori,Masaki; Mimori,Koshi

doi:10.3892/or.2013.2664

October 2013 Volume 30 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

October 2013 Volume 30 Issue 4

Full Size Image

Article

Loss of COP1 expression determines poor prognosisin patients with gastric cancer

Authors:
- Genta Sawada
- Hiroki Ueo
- Tae Matsumura
- Ryutaro Uchi
- Masahisa Ishibashi
- Kosuke Mima
- Junji Kurashige
- Yusuke Takahashi
- Sayuri Akiyoshi
- Tomoya Sudo
- Keishi Sugimachi
- Yuichiro Doki
- Masaki Mori
- Koshi Mimori
View Affiliations / Copyright

Affiliations: Department of Surgery, Beppu Hospital, Kyushu University, Beppu, Oita 874-0838, Japan, Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan
Pages: 1971-1975
|
Published online on: August 8, 2013

https://doi.org/10.3892/or.2013.2664
Expand metrics +

Abstract

Previous studies have suggested conflicting roles for the E3 ubiquitin ligase COP1 in tumorigenesis, providing evidence that both the oncoprotein c-Jun and the tumor suppressor p53 may be COP1 targets. In the present study, we focused on the clinical significance of COP1 expression in gastric cancer cases and analyzed the malignant behavior of COP1‑knockdown gastric cancer cells in vitro. We analyzed COP1 expression in cancer lesions and the corresponding normal mucosa to demonstrate the clinical significance of COP1 expression in 133 cases of gastric cancer. We also investigated the relationship between COP1 expression and cell proliferation and the association of COP1 with c‑Jun transcriptional target genes, such as MMP1, MMP7 and MMP10. The expression of COP1 mRNA was significantly lower in gastric cancer tissues compared to the corresponding normal mucosa (P=0.049). In multivariate analysis for overall survival, we found that COP1 expression was an independent prognostic factor in gastric cancer. Knockdown of COP1 expression in the gastric cancer cell lines MKN‑45 and NUGC4 promoted proliferation, and significant associations between COP1 expression and MMP1, MMP7 and MMP10 were also observed in knockdown assays. In conclusion, the present study suggests that loss of COP1 expression may be a novel indicator for the biological aggressiveness in gastric cancer.

View Figures

View References

1	Guo J, Miao Y, Xiao B, et al: Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 24:652–657. 2009. View Article : Google Scholar : PubMed/NCBI
2	Oh SC: Update of adjuvant chemotherapy for resected gastric cancer. J Gastric Cancer. 12:3–6. 2012. View Article : Google Scholar : PubMed/NCBI
3	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
4	Jemal A, Tiwari RC, Murray T, et al: Cancer statistics, 2004. CA Cancer J Clin. 54:8–29. 2004. View Article : Google Scholar
5	Kelley JR and Duggan JM: Gastric cancer epidemiology and risk factors. J Clin Epidemiol. 56:1–9. 2003. View Article : Google Scholar : PubMed/NCBI
6	Sun P, Xiang JB and Chen ZY: Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg. 96:26–33. 2009. View Article : Google Scholar : PubMed/NCBI
7	Dornan D, Wertz I, Shimizu H, et al: The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature. 429:86–92. 2004. View Article : Google Scholar : PubMed/NCBI
8	Wertz IE, O’Rourke KM, Zhang Z, et al: Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science. 303:1371–1374. 2004. View Article : Google Scholar : PubMed/NCBI
9	Savio MG, Rotondo G, Maglie S, Rossetti G, Bender JR and Pardi R: COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1. Oncogene. 27:2401–2411. 2008. View Article : Google Scholar : PubMed/NCBI
10	Dornan D, Shimizu H, Mah A, et al: ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Science. 313:1122–1126. 2006. View Article : Google Scholar : PubMed/NCBI
11	Dornan D, Bheddah S, Newton K, et al: COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas. Cancer Res. 64:7226–7230. 2004. View Article : Google Scholar : PubMed/NCBI
12	Lee YH, Andersen JB, Song HT, et al: Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma. Cancer Res. 70:8264–8269. 2010. View Article : Google Scholar : PubMed/NCBI
13	Vitari AC, Leong KG, Newton K, et al: COP1 is a tumour suppressor that causes degradation of ETS transcription factors. Nature. 474:403–406. 2011. View Article : Google Scholar : PubMed/NCBI
14	Bianchi E, Denti S, Catena R, et al: Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity. J Biol Chem. 278:19682–19690. 2003. View Article : Google Scholar
15	Deshaies RJ and Joazeiro CA: RING domain E3 ubiquitin ligases. Annu Rev Biochem. 78:399–434. 2009. View Article : Google Scholar : PubMed/NCBI
16	Li YF, Wang DD, Zhao BW, et al: High level of COP1 expression is associated with poor prognosis in primary gastric cancer. Int J Biol Sci. 8:1168–1177. 2012. View Article : Google Scholar : PubMed/NCBI
17	Li DQ, Ohshiro K, Reddy SD, et al: E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proc Natl Acad Sci USA. 106:17493–17498. 2009. View Article : Google Scholar : PubMed/NCBI
18	Wang K, Kan J, Yuen ST, et al: Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet. 43:1219–1223. 2011. View Article : Google Scholar : PubMed/NCBI
19	Zang ZJ, Cutcutache I, Poon SL, et al: Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet. 44:570–574. 2012. View Article : Google Scholar : PubMed/NCBI
20	Migliorini D, Bogaerts S, Defever D, et al: Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice. J Clin Invest. 121:1329–1343. 2011. View Article : Google Scholar : PubMed/NCBI
21	Marine JC: Spotlight on the role of COP1 in tumorigenesis. Nat Rev Cancer. 12:455–464. 2012. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Loss of COP1 expression determines poor prognosisin patients with gastric cancer

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles